Vyvanse 50 MG capsule 100S
Ended Awarded
- Contract number
- SPE2DB25FYEU9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,817
Award facts
- Contract value 100% obligated
- $3,817.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Vyvanse 50 mg capsules (100-count units) with a ceiling value of $3,817.33. This competitive award, which carries no set-aside designation, represents a firm fixed-price delivery order with an ultimate completion date of August 21, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999,999,999.00 prime vendor agreement that extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies an extensive range of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates substantial experience fulfilling diverse therapeutic requirements, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. This award reflects AmerisourceBergen's ongoing role as a primary supplier within the DLA's pharmaceutical supply chain and its capability to meet federal procurement requirements through competitive open competition.
Quick answers
Who was awarded contract SPE2DB25FYEU9?
SPE2DB25FYEU9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 20, 2025.
How much is contract SPE2DB25FYEU9 worth?
The government has obligated $3,817 on SPE2DB25FYEU9.
Is contract SPE2DB25FYEU9 an order under another contract?
Yes. SPE2DB25FYEU9 is a delivery order under SPE2DB24D1104, an indefinite delivery contract.
Was contract SPE2DB25FYEU9 competed?
The extent of competition for SPE2DB25FYEU9 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award